HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$18.91
Day range
$18.11 - $19.28
Year range
$10.00 - $28.42
Market cap
198.33M USD
Avg Volume
109.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.96M | 50.50% |
Net income | -15.98M | -75.52% |
Net profit margin | — | — |
Earnings per share | -2.38 | -32.22% |
EBITDA | -17.35M | -290.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 127.39M | 161.73% |
Total assets | 162.33M | 155.77% |
Total liabilities | 46.70M | -15.75% |
Total equity | 115.63M | — |
Shares outstanding | 7.05M | — |
Price to book | 1.15 | — |
Return on assets | -25.91% | — |
Return on capital | -34.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -15.98M | -75.52% |
Cash from operations | -36.70M | -2,145.72% |
Cash from investing | -106.00K | 15.87% |
Cash from financing | -182.00K | — |
Net change in cash | -36.98M | -2,001.31% |
Free cash flow | -30.69M | -768.21% |
About
Founded
2012
Headquarters
Website
Employees
69
